Clarifications of Lecture #36- Drug Interactions I

Slides:



Advertisements
Similar presentations
Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
Advertisements

Assignment 6 Metabolism
Distribution & Fate Lesson 5. Distribution n Drug disperses throughout system l does not reach target l silent receptors n Distributes in l Blood & extracellular.
Receptors & Signaling. Assumed Knowledge Structure of membrane proteins Ion concentrations across membranes Second messengers in signal transduction Regulation.
Nerve physiology.
Inhibitory and Excitatory Signals
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Cardiotropic Drugs.
Regulation of Metabolism
New Zealand College of Pharmacists
7 December 2014 CHANNELS OF THE NEURON: ACTING ON IMPULSE.
Practical Pharmacokinetics
Dosage Regimens II Arthur G. Roberts. Question Can a drug have a low therapeutic index and a broad therapeutic window? No therapeutic index= [drug] min,toxicity.
Pharmacology Department
AP Biology Nervous Systems Part 2. Animation 7Yk 7Yk.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Quantitative Pharmacokinetics
Pharmacokinetics Introduction
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
Molecular Targets For Drug Action (syllabus -prof.Kršiak) FOUR MAJOR TARGETS FOR DRUGS: 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES 4. ENZYMES.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
PHARMACOKINETICS Part 3.
MECHANISTIC PHARMACOKINETICS: COMPARTMENTAL MODELS
11-2. LIGAND OR CHEMICAL GATE Voltage-Gated Channel Example: Na + channel Figure 11.6b.
May 19, 2005FDA Antiviral Drugs Advisory Committee Meeting 1 Tipranavir NDA Drug Interactions Yuanchao (Derek) Zhang, Ph.D. Clinical Pharmacology.
Errata Lecture 10 Slide 18 Rational because However.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Pharmacology Department
MS Phoenix WinNonLin Project
Action Potential revisited When a stimulus reaches threshold level, Sodium channels open up and Sodium rushes into the axon along the concentration gradient.
MS STUDENTS: QUESTIONS TO KNOW SECTION. Flurbiprofen misspelled!
DRUG INTERACTIONS I Lecture #36. Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism.
CYP
Drugs acting via ion channels and transporters Prof. M. Kršiak Department of Pharmacology, Third Faculty of Medicine Ruská 87, Prague 10, Subject: General.
Pharmacology PHL 101 Abdelkader Ashour, Ph.D. 10 th Lecture.
Grading Average = 91. Errata Michaelis-Menten Derivation KmKm k cat Formation of ES complex is rapid (k cat
AP Biology Nervous Systems Part 3.  I. Synapses – These are the gaps between neurons or between neuron and effector cells.  A. There are two types of.
Graded Potentials & Action Potentials Excitatory Post Synaptic Potential (EPSP) -it results from the opening of ligand-gated Na + channels -some positive.
Action Potentials. Membrane Potential Electrical charge inside a neuron is different than interstitial space Resting membrane potential (RMP) is -70mV.
Pharmacokinetics 2 General Pharmacology M212
Foundation Knowledge and Skills
Electrical Properties of the Nervous System Lundy-Ekman, Chapter 2 D. Allen, Ph.D.
 Chapter 48 Gaby Gonzalez Joyce Kim Stephanie Kim.
Metabolite Kinetics I Arthur G. Roberts. DrugMetabolite Renal Excretion Metabolite of a Metabolite Biliary Excretion keke Options keke keke keke Other.
Pharmacology Tutoring – Factors Affecting Drug Action
Lecture on Anti Diabetic Drugs
Medicinal chemistry Third stage Lecture 1
Toxicology Drug Poisioning.
Pharmacokinetics.
Enzymes and drugs P450 enzymes breakdown/metabolize active drug
Pharmacokinetics.
Pharmacokinetics.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Pharmacokinetics.
Neurons, Synapses and Signaling
Neuronal Networks So far: the building blocks of neurons/networks
Nerve Impulses.
Toxicology Drug Poisioning.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
ION CHANNELS AS DRUG TARGETS &
AP Biology Nervous Systems Part 2.
Introduction to Pharmacology
BIOAVAILABILITY.
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Therapeutic Drug Monitoring
AP Biology Nervous Systems Part 2.
Gates + Potentials.
Alexander Kiani, Anjana Rao, Jose Aramburu  Immunity 
Introduction to Pharmacology
Presentation transcript:

Clarifications of Lecture #36- Drug Interactions I

Mutual Effects

Mutual Effects * Drug Displaced Unbound Bound 100% Drug * 0% C D C D C Low Extraction Ratio IV or Oral High Extraction Ratio IV High Extraction Ratio Oral 100% Drug * 0% C D C D C D Clearance [Drug]plasma

Mutual Effects * Drug Displaced Unbound Bound [Drug] * C D C D C D Low Extraction Ratio IV or Oral High Extraction Ratio IV High Extraction Ratio Oral [Drug] * C D C D C D * Unbound [Drug] the same for Low Extraction Ratio and High Extraction Ratio Oral.

Mutual Effects D = Displaced C = Control Total Unbound

Mutual Effects anti-seizure anti-seizure Extraction Ratio? https://en.wikipedia.org/wiki/Phenytoin https://en.wikipedia.org/wiki/Valproate http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884335/ * This is consistent with increased clearance following displacement from the plasma protein binding site of a highly bound drug with a low hepatic extraction ratio [34]. anti-seizure Extraction Ratio?

Aside: Question of Effect of Ethanol and Benzodiazepines on an Action Potential

Action Potential

Action Potential Depolarization Repolarization

Channel Types Chloride Channels Potassium Channels Sodium Channels Voltage-gated Resting Potential (-70 mV) Ligand-gated Chloride Channels GABAA Receptor Potassium Channels Sodium Channels Voltage-gated/Ligand-gated

Effect of Ethanol or Benzodiazepines Threshold Hyperpolarization Hyperpolarization effect of ethanol/benzodiazepines More difficult to initiate action potentials. 15 mV difference  45 mM difference.

Lecture #37 Drug Interactions II

Interaction Types Mutual Effects Bidirectional Effects Competing for the same target Bidirectional Effects Unidirectional Effects AB Beneficial Interactions

Beneficial Drug Combinations: Inhibit Metabolism penicillin antibiotic dehydropeptidase inhibitor renal dehydropeptidase https://en.wikipedia.org/wiki/Imipenem https://en.wikipedia.org/wiki/Cilastatin Metabolites

Beneficial Interactions

Condition PK Effects Metabolism inhibited Increased t1/2, Decreased CL Metabolism Induced Decreased t1/2, Increased CL

Condition PK Effects CL reduced C avg, ss, altered increased CL increased C avg, ss, altered decreased

Effect of Inhibitors fm = fraction down the metabolism route; CuI = concentration unbound inhibitor.

Effect of Inhibitors

NF-AT = nuclear factor activated T cell Cholesterol Lowering immunosuppressant NF-AT = nuclear factor activated T cell transcription factor

Effect of Inhibitors Cholesterol Lowering CYP2C9 substrate immunosuppressant CYP2C9 inhibitor https://en.wikipedia.org/wiki/Ciclosporin

Route of Administration https://en.wikipedia.org/wiki/Lovastatin https://en.wikipedia.org/wiki/Diltiazem CYP3A inhibitor Cholesterol Lowering Drug Calcium Channel Blocking Drug

Route of Administration https://en.wikipedia.org/wiki/Fluconazole https://en.wikipedia.org/wiki/Midazolam anti-fungal CYP3A inhibitor sedative

Mechanism-Based Inhibition

kobs = rate constant kinact observed kinact = rate of inactivation KI = inhibitory constant Y = [I]/(KI+[I]) http://www.nature.com/protocolexchange/protocols/1951 Remove Slide

Mechanism-Based Inhibition https://en.wikipedia.org/wiki/Clarithromycin

Mechanism-Based Inhibition + Clarithromycin + Clarithromycin https://en.wikipedia.org/wiki/Midazolam https://en.wikipedia.org/wiki/Clarithromycin Antibiotic Sedative

Induction anticoagulant anti-seizure/CYP 2C9 inducer https://en.wikipedia.org/wiki/Dicoumarol https://en.wikipedia.org/wiki/Phenobarbital anticoagulant anti-seizure/CYP 2C9 inducer

Multi-faceted Interactions Examples Displace protein binding and inhibit metabolism Compete with PD target and inhibit metabolism Displace protein binding and induce metabolism

Multi-faceted Interactions anti-coagulant Inhibition of Elimination https://en.wikipedia.org/wiki/Phenylbutazone https://en.wikipedia.org/wiki/Warfarin Phenylbutazone is AKA bute Phenylbutazone displaces Warfarin from Albumin The spike suggests that CYP NSAID Phenylbutazone Protein Binding Displacement Inhibit Elimination

Multi-faceted Interactions https://en.wikipedia.org/wiki/Quinidine https://en.wikipedia.org/wiki/Digoxin Na+/K+ ATPase Inhibitor Quinidine Displaces from tissues (Decreases V) Inhibits Pgp Na+/K+ ATPase Inhibitor

P-gp Inhibition Cause Effect increase intestinal absorption decrease biliary clearance decrease renal clearance Effect decreased biliary and renal clearance increased absorption rate (ka) increased AUC

Multi-faceted Interactions https://en.wikipedia.org/wiki/Rifampicin https://en.wikipedia.org/wiki/Atorvastatin Rifampicin is a CYP3A inducer. Rifampicin is a uptake transport inhibitor (OATP1B1 inhibitor) antibiotic CYP3A inducer/OATP1B1 inhibitor cholesterol lowering (Lipitor)

PD: Additive Effects Saturating A No A

Isobologram Isobologram- Equal concentrations across both axes; or IC50 Line on an Isobologram (Black, Red, Gray) = Isobole

mTOR = mammalian target of rapamycin a.k.a. rapamycin Cotylenin A mTOR = mammalian target of rapamycin gbL = positive regulator of rapamycin-sensitive pathway Raptor (RPTOR)= Regulator-associated protein of mTOR Bcl-2 = B-cell lymphoma 2 (inhibited) induce promote apoptosis reduce apoptosis (rapamycin) BAD (inhibited) p53 (activated) http://www.ncbi.nlm.nih.gov/pubmed/18754885 http://www.ncbi.nlm.nih.gov/pubmed/12718876 https://en.wikipedia.org/wiki/Bcl-2 https://en.wikipedia.org/wiki/RPTOR http://www.ncbi.nlm.nih.gov/pmc/articles/PMC60265/ Inhibits G1-S cell cycle progression http://www.jimmunol.org/content/178/4/2163.full.pdf

Isobologram Cotylenin A Rapamycin = Sirolimus https://openi.nlm.nih.gov/detailedresult.php?img=1410757_bcr1344-2&req=4 http://www.ncbi.nlm.nih.gov/pubmed/18754885 Rapamycin = Sirolimus